Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · IEX Real-Time Price · USD
-0.21 (-1.10%)
Apr 16, 2024, 3:43 PM EDT - Market open

Myriad Genetics Revenue

In the year 2023, Myriad Genetics had annual revenue of $753.20M with 11.03% growth. Revenue in the quarter ending December 31, 2023 was $196.60M with 10.57% year-over-year growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
1.70B USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 2023753.20M74.80M11.03%
Dec 31, 2022678.40M-12.20M-1.77%
Dec 31, 2021690.60M52.00M8.14%
Jun 30, 2020638.60M-212.50M-24.97%
Jun 30, 2019851.10M107.40M14.44%
Jun 30, 2018743.70M15.00M2.06%
Jun 30, 2017728.70M-11.80M-1.59%
Jun 30, 2016740.50M17.40M2.41%
Jun 30, 2015723.10M-55.10M-7.08%
Jun 30, 2014778.20M165.00M26.91%
Jun 30, 2013613.20M117.20M23.63%
Jun 30, 2012496.01M93.92M23.36%
Jun 30, 2011402.08M39.44M10.87%
Jun 30, 2010362.65M36.12M11.06%
Jun 30, 2009326.53M103.67M46.52%
Jun 30, 2008222.86M77.57M53.39%
Jun 30, 2007145.29M31.01M27.13%
Jun 30, 2006114.28M31.87M38.68%
Jun 30, 200582.41M25.76M45.47%
Jun 30, 200456.65M-7.67M-11.93%
Jun 30, 200364.32M10.49M19.48%
Jun 30, 200253.84M8.67M19.21%
Jun 30, 200145.16M11.15M32.78%
Jun 30, 200034.01M8.70M34.37%
Jun 30, 199925.31M2.10M9.06%
Jun 30, 199823.21M7.97M52.34%
Jun 30, 199715.24M8.61M129.85%
Jun 30, 19966.63M5.33M412.06%
Jun 30, 19951.29M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition